Hanan Henidi

7PUBLICATIONS
24CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)ChemotherapyMolecular targetsBiologically active moleculesShip and platform structures (incl. maritime hydrodynamics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Nov 27, 2025
Thymoquinone Overcomes Hypoxia-Induced Carboplatin Resistance Through ROS-Independent Apoptosis but Promotes Cancer Stem Cell Enrichment: Implications on Oral Cancer Adaptation and Recurrence.

Ishrat Rahman, Hanan Henidi, Manal M Alkahtani

|Nov 27, 2025
Cuproptosis Contributes to Cisplatin-Induced Nephrotoxicity: Insights into Thymol's Potential Inhibitory and Protective Effects.

Layla A Al-Kharashi, Amira M Badr, Reem T Atawia

|Sep 27, 2025
Thymol Preserves Spermatogenesis and Androgen Production in Cisplatin-Induced Testicular Toxicity by Modulating Ferritinophagy, Oxidative Stress, and the Keap1/Nrf2/HO-1 Pathway.

Amira M Badr, Sheka Aloyouni, Yasmin Mahran

|Aug 28, 2025
From Hue to Health: Exploring the Therapeutic Potential of Plant-Pigment-Enriched Extracts.

Azza SalahEldin El-Demerdash, Amira E Sehim, Abeer Altamimi

|Dec 17, 2024
Natural Inhibitors of Salmonella MDR Efflux Pumps AcrAB and AcrD: An Integrated In Silico, Molecular, and In Vitro Investigation.

Azza S El-Demerdash, Shimaa A Kamel, Eman Y T Elariny

|Sep 28, 2023
Cytotoxic Potential of Novel Quinoline Derivative: 11-(1,4-Bisaminopropylpiperazinyl)5-methyl-5H-indolo[2,3-b]quinoline against Different Cancer Cell Lines via Activation and Deactivation of the Expression of Some Proteins.

Sara Fathy Abd Elrahman, Abdullah A S Ahmed, Doaa Abd Elsatar

Pageof 2

Frequent Collaborators

4 joint publications

Elshaymaa I Elmongy

2 joint publications

Azza SalahEldin El-Demerdash

2 joint publications

Amira M Badr

1 joint publications

Abdullah A S Ahmed